International Diabetes Federation Europe

12/06/2026

📢 How do we move from simply including young people to genuinely working with them in non-communicable diseases ( ) prevention?

🗣️ IDF Europe’s Youth project coordinator and Young Diabetes Advocate, Cameron Keighron, will represent IDF Europe at the Live Webinar "Beyond the Seat at the Table and More than a Checkbox: A Multi-Stakeholder Dialogue on Youth Engagement in NCD Prevention" on June 16.

💬 He will contribute to the session "Youth-Led Advocacy in Action: The YOURAH Network and Youth Advocacy Committee" at 14:15 CEST, sharing insights on how youth-led advocacy can strengthen NCD prevention efforts and help create meaningful opportunities for young people to shape the policies and initiatives that affect their lives.

🤝 The webinar will bring together diverse stakeholders to explore what meaningful youth engagement looks like in practice, what mechanisms for engagement in NCD prevention already exist, and how to move from consultation to genuine collaboration.

🗓️ June 16
🕒 14:15–15:30 CEST
💻 Online

🌍 We look forward to contributing to this important dialogue and exchanging ideas on how to ensure that young people are not only heard, but empowered to drive change in NCD prevention, including care.

➡️Register here: https://ecconf.webex.com/weblink/register/r53988bb571ff16dbc242df83ebb57ecf

11/06/2026

11/06/2026

✨ Yesterday, we successfully kicked off the with our online Welcoming Session!

👉 Our opening session brought together inspiring voices from across the IDF Europe community and partners. Prof. Tadej Battelino, IDF Europe Chair, together with João Nabais, co-founder of the Young Leaders in Diabetes programme and representative of our hosting organisation APDP Diabetes, played a key role in welcoming this year’s cohort.

🤝We were also joined by our valued partners, with contributions from Paco Orengo, MiniMed, and Ludovica Florenzano, LillyDiabetes who shared their continued commitment to supporting advocacy and the YLL programme.

🗣️Throughout the session, the programme goals and activities were presented by the Steering Committee Coordinator and IDFE Board Member Uroš Bogdanovic, followed by the introduction of the IDFE team and the YLL faculty, who set the tone for an inspiring and impactful journey ahead.

🙌The session continued with the introduction of this year’s mentors and participants, marking a very special moment as the group came together for the first time. With 20 participants and 8 mentors this year, the room (and screen) was filled with energy, curiosity and shared purpose.

💙Over five immersive days, during this year’s YLL, mentors will work closely with participants in small group settings, guiding them through key themes such as stigma in travel, youth voices in , access and safety of diabetes technology and . Since 2023, near-peer mentoring has become a cornerstone of the programme, transforming it into a two-way learning experience where both mentors and participants grow, learn and inspire each other.

🌍 We were thrilled to welcome this year’s participants into the YOURAH network and to witness the beginning of what promises to be a transformative journey in advocacy, learning and leadership.

💬A big thank you to everyone who joined and contributed to making this opening session such a meaningful start.

10/06/2026

📢 T2GETHER Advocacy Training Programme – Module 2 Complete!

This week, participants explored the foundations of advocacy and how lived experience can become a powerful tool for change.

Together, we discussed:
✅ What advocacy means in the context of type 2 diabetes ( )
✅ Why and how people living with diabetes become advocates
✅ The different levels of advocacy, from personal conversations to influencing policy
✅ Real-world examples of engagement with healthcare professionals, researchers, policymakers and patient organisations

One key message stood out: you are not alone. Advocacy is stronger when we work together, support one another and combine our voices to create change and ensure that the experiences of people living with T2D are heard.

Thank you to our speakers Borislava Ananieva from European Patients' Forum and Janne Mikkonen from Diabetesliitto ry and participants for contributing to an inspiring discussion on transforming lived experience into meaningful action.

We are looking forward to our next module in two weeks' time!

If you are interested in T2D advocacy in Europe, you can find out more about our T2GETHER community and contact us here https://idf.org/europe/our-network/t2d-platform/

10/06/2026

💙This week, IDF Europe’s Project Co-ordinator, Cameron Keighron, is attending the JA PreventNCD General Assembly in Rome.

👉Yesterday, they had the opportunity to share some reflections on whether our monitoring systems in Europe are able to identify risks early enough to effectively protect people and reduce NCD risk.

Three messages they brought to the room:

➡️NCD prevention isn't experienced as a policy framework, it's experienced in shops, on a social media feed or in the price of a product, in everyday life.
➡️Markets reach people before regulation does and that gap is a protection gap
➡️Young people and those with lived experience can act as an early warning system, but only if their insight shapes monitoring systems from the outset, not as an afterthought.

💡Future-proofing prevention means aligning policy and monitoring systems with people’s real-world experiences and shifting from reactive monitoring to anticipatory public health.

09/06/2026

💙 A week of prevention, awareness and action at the Liver Disease Prevention Village organised led by European Liver Patients' Association

👉 Over five days at the European Parliament in Brussels, more than 500 visitors engaged with healthcare professionals, advocates and experts to learn more about the links between liver disease, type 2 diabetes ( ), obesity, cardiovascular diseases and cancer.

🔬 At IDF Europe’s booth, participants had the opportunity to assess their risk of developing T2D and learn more about the importance of early detection and prevention. The strong interest shown throughout the week highlighted the growing need for integrated screening and prevention strategies.

🗣️ As part of the initiative, IDF Europe’s Regional Manager, Elisabeth Dupont, also participated in a high-level roundtable at the European Parliament on the early detection and management of MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease). During the discussion, she highlighted that despite people living with T2D being at high risk of MASLD, liver assessment is still not routinely integrated into diabetes care pathways.

💡 The discussions throughout the week reinforced a key message: diabetes does not exist in isolation. A shared approach targeting common risk factors for diabetes, obesity, liver, kidney and cardiovascular diseases — along with early detection and timely access to treatment initiation — is key to protecting health, delaying or reversing.

🙌 A sincere thank you to everyone who visited the Village, participated in screenings and conversations, and contributed to advancing awareness, prevention and integrated care.

09/06/2026

08/06/2026

08/06/2026

A new consensus with recommendations to guide safe use of GLP-1 and dual GLP-1/GIP receptor agonists for people with type 1 diabetes ( ) was just published, endorsed by IDF Europe and Advanced Technologies & Treatments for Diabetes (ATTD).

T1D is complex and demanding to manage— yet approved treatment options to address complication, dysglycemia, and metabolic concerns for people with T1D remain quite limited. As off-label use of GLP-1 and dual GLP-1/GIP receptor agonists becomes increasingly common among people with T1D to address these unmet needs, the new expert consensus provides a framework for safe use while large trials are still ongoing.

The diaTribe Foundation gathered clinicians experienced with prescribing these medications for people with T1D to review existing evidence and develop clear guidance for using these medications safely in T1D management.

Check out the publication in Diabetes Technology & Therapeutics here:

Among the most impactful therapeutic advances in the management of diabetes over the past two decades has been the development of incretin-based therapies, spec...

05/06/2026

🌍 World Environment Day: why climate action is also action

🌡️ Climate change is one of the defining health challenges of our time, with increasingly serious consequences for people living with diabetes ( ). Risks include heat stress, dehydration and cardiovascular strain, which can complicate diabetes management and diabetes-related complications during extreme heat events.

🔥 During heatwaves, these risks translate into measurable health impacts, with studies reporting increases of up to 30% in diabetes-related emergency visits and hospital admissions, as well as significantly increased mortality.

🌬️ Climate change is also reinforcing one of the major environmental risk factors for type 2 diabetes ( ): air pollution, highlighting a clear bidirectional relationship between environmental degradation and metabolic health.

📊 According to recent evidence, around 20% of global T2D cases may be linked to long-term exposure to fine particulate matter (PM) with a diameter of 2.5 μm or less. Air pollution may contribute to T2D development through pathways including chronic inflammation, oxidative stress, and impaired insulin sensitivity. Air pollution is now considered the third leading environmental risk factor for T2D, with more than 99% of the world's population living in areas where air pollution exceeds WHO guideline levels.

🍎 At the same time, climate-related disruptions to food systems can increase food insecurity and make healthy diets less accessible, further raising the risk of obesity and T2D, particularly among vulnerable populations.

🏥 The relationship works both ways. Healthcare systems account for nearly 5% of global greenhouse gas emissions, highlighting the need to build more sustainable models of care. Evidence suggests that improving diabetes management and preventing complications can reduce healthcare-related carbon emissions while delivering better outcomes for people living with diabetes.

🤝 Addressing climate change and diabetes requires integrated solutions: cleaner air, healthier urban environments, active mobility, equitable access to nutritious food, resilient healthcare systems and strong prevention policies.

💚 This World Environment Day, we are reminded that targeting climate change is also an opportunity to lower the risk of diabetes, improve health outcomes and build healthier futures for all.